🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "targeted action to deal with cost of living issues" in the forthcoming Budget.

Speaking to media outlets, she noted that curbing inflation is a collective responsibility of both the government and the central bank.

The UK's price growth is projected to be the most elevated among the G7 developed nations this year and the following year.

Potential Utility Bill Measures

Reports indicate the administration could intervene to bring down energy bills, for example by cutting the current 5% rate of VAT applied on energy supplies.

Another approach is to cut some of the policy costs presently included in bills.

Budgetary Constraints and Analyst Expectations

The administration will receive the next report from the official forecaster, the OBR, on the start of the week, which will clarify how much space there is for such actions.

The consensus from the majority of experts is that the Chancellor will have to announce higher taxes or expenditure reductions in order to fulfill her declared debt limits.

Previously on Thursday, calculations suggested there was a twenty-two billion pound shortfall for the Treasury chief to address, which is at the lower end of forecasts.

"There's a collective job between the Bank of England and the government to continue tackling some of the drivers of price increases," Reeves informed the BBC in the US capital, at the yearly gatherings of the IMF and World Bank.

Revenue Pledges and International Concerns

While much of the focus has been on expected tax rises, the Treasury chief said the latest data from the fiscal watchdog had not altered her vow to election pledges not to raise rates on earnings tax, VAT or social security contributions.

She attributed an "unpredictable global environment" with increasing international and trade concerns for the fiscal tax moves, probably to be directed on those "wealthiest."

Global Trade Tensions

Commenting on worries about the United Kingdom's trade ties with the Asian nation she said: "Our security interests invariably take priority."

Last week's announcement by Chinese authorities to tighten export controls on rare earths and other materials that are key for advanced tech production led American leader Donald Trump to suggest an further 100% import tax on imports from China, raising the prospect of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary described the Chinese move "economic coercion" and "a international production power grab."

Asked about accepting the American proposal to join its conflict with China, Reeves said she was "very concerned" by China's actions and encouraged the Beijing authorities "not to put up barriers and limit trade."

She said the action was "bad for the world economy and creates further challenges."

"In my view there are sectors where we should confront Chinese policies, but there are also important chances to sell into China's economy, including financial services and other sectors of the economic system. We've got to maintain that equilibrium right."

The Treasury chief also confirmed she was cooperating with international partners "on our own critical minerals plan, so that we are reduced dependence."

Health Service Drug Pricing and Investment

The Chancellor also recognized that the price the National Health Service pays for drugs could go up as a result of ongoing discussions with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and investment.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or scrapping projects in the United Kingdom, with several attributing the low prices they are receiving.

Recently, the government science advisor said the price the health service pays for medicines would have to increase to stop companies and pharmaceutical investment leaving the UK.

The Chancellor informed media: "It has been observed due to the pricing regime, that medical research, innovative medicines have not been available in the United Kingdom in the extent that they are in other EU nations."

"The objective is to make sure that individuals getting treatment from the National Health Service are able to receive the top life-saving treatments in the world. And so we are looking at this situation, and... looking to obtain more investment into Britain."